Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., authorizing changes under the appro…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride (generic), enabling continued marketing of the product.
-
FDA approval · 2024-10-31FDA Approved: BUPRENORPHINE — Supplemental Application (INGENUS PHARMACEUTICALS, LLC)
The FDA approved a supplemental application for buprenorphine from Ingenus Pharmaceuticals, granting approval of a generic buprenorphine pro…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approves SpecGx LLC's supplemental application for methadone hydrochloride.
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., supporting its continued availabili…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., confirming the generic product's ap…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: FAVOR Opioid Recovery Coaching Evaluation [NA]
The FAVOR Opioid Recovery Coaching Evaluation trial has completed; it examines a recovery coaching approach for opioid-use disorder and rela…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: SafetyNet Program for Opioid Use Disorder (OUD) [NA]
A ClinicalTrials.gov update indicates the SafetyNet Program for Opioid Use Disorder has completed and results have been posted as of October…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
This clinical trial update from Kaiser Permanente examines how health insurance instability affects mortality among patients receiving bupre…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study [Phase 2]
Filament Health Corp. is conducting a Phase 2 feasibility trial of PEX010 for opioid use disorder; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery [Phase 2]
Phase 2 clinical trial investigating brain mechanisms of relapse and recovery in individuals with prescription opioid dependence has complet…
-
FDA approval · 2024-10-10FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (INGENUS PHARMACEUTICALS, LLC)
FDA approved a supplemental application for buprenorphine and naloxone from Ingenus Pharmaceuticals under ANDA212756.
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Improving Health and Employment Outcomes Through Workplace Opioid Policies [NA]
This completed clinical trial analyzed whether implementing workplace opioid policies improves health and employment outcomes for individual…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder [Phase 2]
A Phase 2 study examining dual-orexin receptor antagonism to improve sleep and support abstinence in opioid use disorder has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Neurofeedback in Individuals With Substance Use Disorders [NA]
The Yale-sponsored trial evaluating neurofeedback for opioid use disorder was terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders [NA]
This document provides an update on an ongoing Clemson University clinical trial evaluating trauma screening, referral, and interpersonal vi…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction
A UC San Diego trial is leveraging AI and multi-omics data to predict opioid use disorder and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Microcurrent Treatment for Chronic Debilitating Pain [NA]
This clinical trial update shows that a study of microcurrent treatment for chronic debilitating pain has completed. The update does not pro…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: MBC2OTP Project (Measurement-Based Care Implementation in Community Opioid Treatment Programs) [NA]
A Northwestern University-sponsored clinical trial is recruiting to evaluate Measurement-Based Care implementation in community opioid treat…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Perinatal Opioid Use
The update confirms the completion of a clinical trial studying opioid use during pregnancy, sponsored by the Medical University of South Ca…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
This clinical trial update describes a study of hepatitis C treatment to prevent HIV infection, initiation of opioid substitution therapy wi…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Increasing Access to Evidence-based Treatment for Chronic Pain and Opioid Use Disorder: Adapting Acceptance and Commitment Therapy for Opioid Treatment Programs [NA]
Completed clinical trial evaluating adapting Acceptance and Commitment Therapy for opioid treatment programs to improve treatment for opioid…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: A Trial of Directly Observed and Long-term Varenicline [Phase 4]
Phase 4 trial evaluating directly observed and long-term varenicline for tobacco use disorder, including participants with opioid use disord…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT) [Phase 4]
A Phase 4 clinical trial evaluating switching virologically suppressed people living with HIV on opioid agonist therapy from their current A…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: The Heroes Circle Opioid Project
This clinical trial update indicates the completion of a study investigating interventions for opioid use disorder sponsored by Wayne State …